253 related articles for article (PubMed ID: 34936683)
1. Kaposi's sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis.
Chen W; Ding Y; Liu D; Lu Z; Wang Y; Yuan Y
PLoS Pathog; 2021 Dec; 17(12):e1009600. PubMed ID: 34936683
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
3. Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.
Li Y; Zhong C; Liu D; Yu W; Chen W; Wang Y; Shi S; Yuan Y
Cancer Res; 2018 Jan; 78(1):230-245. PubMed ID: 29066510
[TBL] [Abstract][Full Text] [Related]
4. Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Gutierrez KD; Morris VA; Wu D; Barcy S; Lagunoff M
J Virol; 2013 Jun; 87(12):6758-68. PubMed ID: 23552426
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus promotes mesenchymal-to-endothelial transition by resolving the bivalent chromatin of PROX1 gene.
Ding Y; Chen W; Lu Z; Wang Y; Yuan Y
PLoS Pathog; 2021 Sep; 17(9):e1009847. PubMed ID: 34492084
[TBL] [Abstract][Full Text] [Related]
6. Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming.
Cancian L; Hansen A; Boshoff C
Trends Cell Biol; 2013 Sep; 23(9):421-32. PubMed ID: 23685018
[TBL] [Abstract][Full Text] [Related]
7. Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells.
Sakakibara S; Pise-Masison CA; Brady JN; Tosato G
J Virol; 2009 Mar; 83(5):2140-53. PubMed ID: 19091861
[TBL] [Abstract][Full Text] [Related]
8. PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment.
Naipauer J; Rosario S; Gupta S; Premer C; Méndez-Solís O; Schlesinger M; Ponzinibbio V; Jain V; Gay L; Renne R; Chan HL; Morey L; Salyakina D; Abba M; Williams S; Hare JM; Goldschmidt-Clermont PJ; Mesri EA
PLoS Pathog; 2019 Dec; 15(12):e1008221. PubMed ID: 31881074
[TBL] [Abstract][Full Text] [Related]
9. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of HDAC5 by Viral Interferon Regulatory Factor 3 Plays an Essential Role in Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphangiogenesis.
Lee HR; Li F; Choi UY; Yu HR; Aldrovandi GM; Feng P; Gao SJ; Hong YK; Jung JU
mBio; 2018 Jan; 9(1):. PubMed ID: 29339432
[TBL] [Abstract][Full Text] [Related]
11. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
[TBL] [Abstract][Full Text] [Related]
12. Human Mesenchymal Stem Cells of Diverse Origins Support Persistent Infection with Kaposi's Sarcoma-Associated Herpesvirus and Manifest Distinct Angiogenic, Invasive, and Transforming Phenotypes.
Lee MS; Yuan H; Jeon H; Zhu Y; Yoo S; Shi S; Krueger B; Renne R; Lu C; Jung JU; Gao SJ
mBio; 2016 Jan; 7(1):e02109-15. PubMed ID: 26814175
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
14. The Kaposi's sarcoma progenitor enigma: KSHV-induced MEndT-EndMT axis.
Naipauer J; Mesri EA
Trends Mol Med; 2023 Mar; 29(3):188-200. PubMed ID: 36635149
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa Stimulates Inflammation and Enhances Kaposi's Sarcoma Herpesvirus-Induced Cell Proliferation and Cellular Transformation through both Lipopolysaccharide and Flagellin.
Markazi A; Bracci PM; McGrath M; Gao SJ
mBio; 2020 Nov; 11(6):. PubMed ID: 33173008
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
Gramolelli S; Ojala PM
Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
[TBL] [Abstract][Full Text] [Related]
17. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.
Ojala PM; Schulz TF
Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643
[TBL] [Abstract][Full Text] [Related]
18. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
Nakayama R; Ueno Y; Ueda K; Honda T
Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma.
Gruffat H; Sergeant A; Manet E
Microbes Infect; 2000 May; 2(6):671-80. PubMed ID: 10884618
[TBL] [Abstract][Full Text] [Related]
20. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.
Cheng F; Pekkonen P; Laurinavicius S; Sugiyama N; Henderson S; Günther T; Rantanen V; Kaivanto E; Aavikko M; Sarek G; Hautaniemi S; Biberfeld P; Aaltonen L; Grundhoff A; Boshoff C; Alitalo K; Lehti K; Ojala PM
Cell Host Microbe; 2011 Dec; 10(6):577-90. PubMed ID: 22177562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
